NASDAQ:ZBIO | Cash Flow Statement | Zenas BioPharma, Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$111.46M
2026-03-31-$80.99M-$75.2M$2,000.00$31.61M$433.48M
2025-12-31-$240.44M-$52.41M$0.00-$93.36M$140.84M
2025-09-30-$51.5M
2025-06-30-$52.22M
2025-03-31-$33.57M-$37.05M$18,000.00-$86.27M$99,000.00
2024-12-31-$52.6M-$38.55M$74,000.00-$3.74M$1.85M
2024-09-30-$38.61M
2024-06-30-$37.98M
2024-03-31-$27.8M-$19.1M$22,000.00-$22,000.00-$614,000.00
2023-12-31-$24.59M-$15.4M$50,000.00
2023-09-30$35.61M
2023-06-30-$29.05M
2023-03-31-$19.1M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$377.74M-$172.33M$18,000.00-$251.89M$215.28M
2024-12-31-$156.99M-$119.67M$131,000.00-$30.55M$412.96M
2023-12-31-$37.12M-$30.53M$17,000.00-$17,000.00$20.12M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.